Skip to content

Nuvation Bio NUVB Gross Profit

Discontinued — last reported Q3 '25

Gross Profit at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$8.07B-1.2%
Pfizer logo
PfizerPFE
$10.9B+0.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$21.81M+2.9%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$79.1M+108%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Incyte logo
IncyteINCY

Other financials

Income statement

See full
Revenue$83.2M+2,599%
Operating income$3.9M+107%
Net income$5.4M+110%
EPS (diluted)$0.01+106%

Balance sheet

See full
Cash & equivalents$125.4M+161%
Total debt$57.2M+401%
Total equity$319.6M-23.8%
Total assets$610.2M+23.9%

Cash flow

See full
Operating cash flow$5.1M+112%
CapEx$48.0K-33.3%
Free cash flow$5.0M+112%

Valuation

See full
Market cap$2.1B+150%
Enterprise value$2.03B+154%
P/S14.7×-62.0×

Profitability

See full
Gross margin54.3%+39.5pp
Operating margin-105%-52.0pp
Net margin-102.1%-50.6pp
FCF margin-93.5%-45.2pp

Returns & leverage

See full
Return on equity-39.5%-15.8pp
Debt / equity0.2×+0.2×
Current ratio7.4×-1.6×

Where this comes from

Calculated from Nuvation Bio’s reported figures.

The official record: Nuvation Bio’s 10-Q, filed November 3, 2025, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's gross profit?
Nuvation Bio (NUVB) reported gross profit of $9.77M in Q3 2025.
How has Nuvation Bio's gross profit changed year-over-year?
Nuvation Bio's gross profit increased by 1340.0% year-over-year, from -$788K to $9.77M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.